Understanding the drivers of value creation for biopharmaceuticals around the time of drug launch
Thesis (S.M.)--Harvard-MIT Program in Health Sciences and Technology, 2012.
Main Author: | You, Sung Min |
---|---|
Other Authors: | Brian Pereira and Jonathan D. Fleming. |
Format: | Thesis |
Language: | eng |
Published: |
Massachusetts Institute of Technology
2012
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/72919 |
Similar Items
-
Understanding risk in a biopharmaceutical portfolio
by: Wagner, Alice Elizabeth, 1980-
Published: (2012) -
Trends in U.S. regulatory approvals of the biopharmaceutical therapeutic entities
by: Graham, James B., 1976-
Published: (2006) -
Value creation through modernizing Chinese medicine
by: Sun, Lizhe
Published: (2008) -
Drug eluting prosthetic joints through drug cluster morphology control
by: Suhardi, Vincentius Jeremy
Published: (2017) -
Understanding vertebral fracture risk in astronauts
by: Burkhart, Katelyn A.
Published: (2019)